Blocking the PROX1 protein allowed KAIST researchers to regenerate damaged retinas and restore vision in mice. Vision is one ...

Key treatments for Alzheimer’s, rare cancers, and infectious diseases are under review, with new vaccines and therapies like ...

These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They include: ...

Akeso, Inc. (9926.HK) ("Akeso" or the "Company") is excited to announce that its globally first-in-class PD-1/VEGF bispecific antibody, ivonescimab, has received approval from the National Medical ...

Summit Therapeutics' partner Akeso received FDA approval for penpulimab-kcqx in NPC, while ivonescimab showed strong data in ...

"Moreover, the duration of follow-up is among the longest reported for a lentiviral vector-based gene therapy; 13 patients ...

gene detection, chemical reagents, biological reagents, laboratory instruments, protein&antibody, gene regulation, and more. This creates robust delivery capabilities and synergistic product ...

Explore seven biotech companies advancing clinical drugs in the race for regulatory approval to revolutionize hepatitis B ...

The risk of MS is significantly higher in people with a specific gene variant called HLA-E*01:01 and a history of mono, a study found.

Researchers have developed a tau-targeting vaccine that could help prevent the progression of Alzheimer’s disease by ...

From egg prices to pet food recalls – and now, confirmation that another strain of bird flu has infected a large commercial ...